FiercePharma

Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium in the U.S.

Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium in the U.S. Paris, France - July 23, 2010 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has reservations on ...
FiercePharma

Sanofi taps local drugmaker Minapharm to crank out popular blood thinner Clexane in Egypt

Sanofi has been in the Egyptian manufacturing game for decades, but that doesn’t mean the French pharma can’t use a helping hand from time to time. Take for instance the company’s new deal with local ...
MM&M

Euro RSCG Life to handle all new diabetes, thrombosis comms for Sanofi-Aventis

Sanofi-Aventis appointed Euro RSCG Life to handle all communications programs for all new diabetes and thrombosis drugs while renewing the network’s global assignments on Lovenox/Clexane, Lantus and ...
Europa Press

New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Sy

PARIS, September 2 /PRNewswire/ -- Sanofi-aventis announced today that one year findings from the landmark ExTRACT-TIMI 25 and STEEPLE studies confirm clear net clinical benefit for patients with ...
FierceBiotech

Sanofi unleashes iPhone app for heparin dosing

Sanofi's unit in Spain has unleashed a mobile app called CLX Dosis for calculating doses of its anticoagulant Clexane (enoxaparin). As PMLive reports, the French drug ...